TNGX
USDTango Therapeutics Inc.
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$7.890
Kõrge
$8.170
Madal
$7.470
Maht
2.98M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
1.1B
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
2.68M
Börs
NGM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
BOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ:TNGX), today announced that it will report third quarter 2025 financial results on November 4, 2025 at 9:00am ET, before the open of the U.S.
Guggenheim Maintains Buy on Tango Therapeutics, Raises Price Target to $12
Guggenheim analyst Charles Zhu maintains Tango Therapeutics with a Buy and raises the price target from $10 to $12.
Tango Therapeutics Announces $225 Million Financing
BOSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ:TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines,
Tango Therapeutics Reports Positive Data from Ongoing Phase 1/2 Study with Vopimetostat (TNG462) in Patients with MTAP-deleted Cancers
– 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months with an objective response rate (ORR) of 25% – – Combination studies with RAS(ON) inhibitors ongoing, data anticipated 2026 – – 49%
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.